Taro Pharmaceutical Industries Ltd. (TARO)

TARO Revenue

Taro Pharmaceutical Industries had revenue of $610.83M in the twelve months ending December 31, 2023, with 7.23% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $157.15M with 12.89% year-over-year growth. In the fiscal year ending March 31, 2023, Taro Pharmaceutical Industries had annual revenue of $572.95M with 2.07% growth.

• Revenue (ttm): $610.83M
• Revenue Growth: +7.23%
• P/S Ratio: 2.61
• Revenue / Employee: $393,068
• Employees: 1,554
• Market Cap: 1.60B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2023	572.95M	11.61M	2.07%
Mar 31, 2022	561.35M	12.38M	2.25%
Mar 31, 2021	548.97M	-95.80M	-14.86%
Mar 31, 2020	644.77M	-25.12M	-3.75%
Mar 31, 2019	669.89M	7.98M	1.21%
Mar 31, 2018	661.91M	-217.47M	-24.73%
Mar 31, 2017	879.39M	-71.36M	-7.51%
Mar 31, 2016	950.75M	87.81M	10.18%
Mar 31, 2015	862.94M	103.66M	13.65%
Mar 31, 2014	759.29M	88.33M	13.16%
Mar 31, 2013	670.95M	127.87M	23.55%
Mar 31, 2012	543.08M	37.41M	7.40%
Dec 31, 2011	505.67M	113.13M	28.82%
Dec 31, 2010	392.54M	36.60M	10.28%
Dec 31, 2009	355.94M	26.90M	8.18%
Dec 31, 2008	329.04M	9.48M	2.97%
Dec 31, 2007	319.55M	67.29M	26.67%
Dec 31, 2006	252.27M	-36.35M	-12.60%
Dec 31, 2005	288.62M	17.64M	6.51%
Dec 31, 2004	270.99M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.